18
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Cytotoxicity, Cell-Cycle Arrest, and Apoptotic Induction of Three Ruellia tuberosa Leaf Extracts in MCF-7 Cells

, &
Pages 504-515 | Received 02 Aug 2023, Accepted 13 Sep 2023, Published online: 08 Nov 2023
 

Abstract

This study investigated the mechanisms responsible for the antiproliferative activities of three Ruellia tuberosa (RT) leaf extracts against MCF-7 cells after liquid-liquid partitioning. Among these extracts, methanol leaf extract exhibited the greatest inhibition of cell growth compared to water and hexane extracts. Results from JC-1 staining and apoptosis assay demonstrated that these leaf extracts induced apoptosis via caspase or mitochondrial independent manner as only substantial apoptotic cells with no obvious loss of mitochondrial membrane potential were found. However, the decrease in the BCL-2/BAX ratio is due to upregulated BAX expression, implying cells undergoing apoptosis. The expression of caspase 9 was unaltered except for cells treated with hexane leaf extract. Additionally, perturbation of cell cycle progression mainly at G1 or S phases was noticeable in treated cells and concentration-dependent. The distinct effect of different leaf extracts on the cell cycle was also reflected by the dysregulation of cyclins (A2 or E1) and cyclin-dependent kinase (CDK6). These findings have unveiled the therapeutical value of RT leaf extracts in breast cancer.

GRAPHICAL ABSTRACT

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.